As interest in psychedelic-assisted therapy grows, an important policy question remains largely unaddressed: who is responsible for ensuring safe, equitable, and accountable implementation within cancer care systems? This poster explores the emerging governance landscape for psychedelic-assisted therapy in Canada. Abstract Background: Psilocybin-assisted therapy (PAT) is emerging as a promising...
The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) was launched in 2025 to address urgent gaps in supportive care for Canadians with cancer experiencing demoralization syndrome (loss of meaning, dysphoria, disheartenment, helplessness, a sense of failure) and related psychosocial distress. CAN-PACT has six major objectives: (1) to develop a national interdisciplinary...
Demoralization syndrome (DS) - a distinct clinical entity characterized by helplessness, hopelessness, and a persistent loss of meaning - affects approximately one in five Canadians with advanced cancer and is associated with increased desire for hastened death, negative clinical outcomes, and higher economic burden, yet recognition and treatment of DS remains suboptimal in modern oncology....